A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers

Clinical trial NCT06422403 · RECRUITING

Trial details

NCT number: NCT06422403
Sponsor: National University Hospital, Singapore
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular Gastric Adenocarcinoma GastroEsophageal Cancer Oesophageal Cancer Non-small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2024-11-25
Primary completion: 2029-03-30
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.